Skip to main navigation Skip to search Skip to main content

Corrigendum to “RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer” [Cellular Signaling, 48 (2018) 38–44, (S0898656818300925), (10.1016/j.cellsig.2018.04.006)]

  • Ke Hui
  • , Shiqi Wu
  • , Yangyang Yue
  • , Yanan Gu
  • , Bing Guan
  • , Xinyang Wang
  • , Jer Tsong Hsieh
  • , Luke S. Chang
  • , Dalin He
  • , Kaijie Wu
  • The First Affiliated Hospital of Xi’an Jiaotong University
  • University of Texas Southwestern Medical Center

Research output: Contribution to journal › Comment/debate

Abstract

The authors regret that the representative picture (Fig. 2, panel B) to show the HUVECs tube formation from 253J-BV NC was misused (marked with a red box), which was same with 5637 KD1 (marked with a blue box). We have corrected this figure, and the conclusions are not changed.[Figure presented] The authors would like to apologize for any inconvenience caused.

Original languageEnglish
Article number112730
JournalCellular Signalling
DOIs
StateAccepted/In press - 2026
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Corrigendum to “RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer” [Cellular Signaling, 48 (2018) 38–44, (S0898656818300925), (10.1016/j.cellsig.2018.04.006)]'. Together they form a unique fingerprint.

Cite this